This subtype has a high potential for bone metastasis.6 TNBC, which accounts for 10-15% of breast cancers, is another subtype without HER2 and is aggressive, with the higher recurrence rate than all HER2+ breast cancers 7,8. This evidence concerns the gene ERBB2 and breast cancer.